Human trials have reported promising results after the team discovered that jab could provide “double protection” against the virus.
Blood samples taken from volunteers in phase one trials have shown that the vaccine has stimulated the body to produce antibodies and T cells, according to a report by the Daily Telegraph.
T cells play a central role in the body’s immune response.
A source told the newspaper that the suit “will hopefully keep people safe.”
The vaccine is one of more than 100 in development coronavirus continues to spread – infecting more than 13 million people and killing at least 582,000.
David Carpenter, chairman of the Berkshire research ethics board, which approved the Oxford trial, said the vaccine team was “absolutely on the right track.”
He added: “No one can set final dates … things could go wrong but the reality is that by working with a large pharmaceutical company, this vaccine could be fairly widely available around September and that is the kind of goal they’re working on. ”
The development of the vaccine is supported by the British government and AstraZeneca.
The pharmaceutical company’s chief executive said last month that phase one trials must end and that a phase three trial has started, which will see the vaccine administered to thousands of people so they can test it. efficacy and safety.
The company has concluded agreements for provide approximately two billion doses worldwide, although it is not yet certain that the vaccine will work.
The vaccine is based on a weakened version of the common cold that causes infections in chimpanzees.
It also contains the genetic material for the cutting edge protein of SARS-CoV-2 – the coronavirus strain that causes COVID-19 disease.
The British government has also donated £ 41 million for the development of another coronavirus vaccine developed by Imperial College London.
If the vaccine works, it will first be given to the most vulnerable, such as the elderly and healthcare workers, he said.
The government will also allow technicians, nurses and pharmacists to give the vaccine, as well as general practitioners.
Nurses and pharmacists can already administer certain vaccines without a medical prescription.